As of 2025-12-24, the Relative Valuation of Charles River Laboratories International Inc (CRL) is 26.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 202.87 USD, the upside of Charles River Laboratories International Inc based on Relative Valuation is -86.8%.
The range of the Relative Valuation is (53.87) - 151.73 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.8x - 35.4x | 33.6x |
| Forward P/E multiples | 25.0x - 40.9x | 29.8x |
| Fair Price | (53.87) - 151.73 | 26.83 |
| Upside | -126.6% - -25.2% | -86.8% |
| Date | P/E |
| 2025-12-23 | -119.61 |
| 2025-12-22 | -119.70 |
| 2025-12-19 | -116.18 |
| 2025-12-18 | -114.29 |
| 2025-12-17 | -115.55 |
| 2025-12-16 | -115.10 |
| 2025-12-15 | -116.83 |
| 2025-12-12 | -113.81 |
| 2025-12-11 | -114.63 |
| 2025-12-10 | -114.88 |
| 2025-12-09 | -109.66 |
| 2025-12-08 | -110.32 |
| 2025-12-05 | -108.67 |
| 2025-12-04 | -108.51 |
| 2025-12-03 | -108.88 |
| 2025-12-02 | -103.04 |
| 2025-12-01 | -103.82 |
| 2025-11-28 | -105.03 |
| 2025-11-26 | -105.50 |
| 2025-11-25 | -104.98 |
| 2025-11-24 | -100.49 |
| 2025-11-21 | -98.84 |
| 2025-11-20 | -95.56 |
| 2025-11-19 | -95.30 |
| 2025-11-18 | -95.83 |
| 2025-11-17 | -95.95 |
| 2025-11-14 | -98.94 |
| 2025-11-13 | -99.76 |
| 2025-11-12 | -101.11 |
| 2025-11-11 | -102.29 |
| 2025-11-10 | -99.62 |
| 2025-11-07 | -99.08 |
| 2025-11-06 | -100.75 |
| 2025-11-05 | -98.87 |
| 2025-11-04 | -104.86 |
| 2025-11-03 | -105.45 |
| 2025-10-31 | -106.17 |
| 2025-10-30 | -105.60 |
| 2025-10-29 | -106.21 |
| 2025-10-28 | -110.80 |
| 2025-10-27 | -115.13 |
| 2025-10-24 | -116.17 |
| 2025-10-23 | -112.59 |
| 2025-10-22 | -110.25 |
| 2025-10-21 | -111.00 |
| 2025-10-20 | -108.57 |
| 2025-10-17 | -105.25 |
| 2025-10-16 | -103.15 |
| 2025-10-15 | -100.65 |
| 2025-10-14 | -100.31 |